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Biology and pathogenesis of Acanthamoeba
Ruqaiyyah Siddiqui1 and Naveed Ahmed Khan1,2*
Abstract
Acanthamoeba is a free-living protist pathogen, capable of causing a blinding keratitis and fatal granulomatous
encephalitis. The factors that contribute to Acanthamoeba infections include parasite biology, genetic diversity,
environmental spread and host susceptibility, and are highlighted together with potential therapeutic and
preventative measures. The use of Acanthamoeba in the study of cellular differentiation mechanisms, motility and
phagocytosis, bacterial pathogenesis and evolutionary processes makes it an attractive model organism. There is a
significant emphasis on Acanthamoeba as a Trojan horse of other microbes including viral, bacterial, protists and
yeast pathogens.
Background
Acanthamoeba is an opportunistic protist that is ubiqui-
tously distributed in the environment. Acanthamoeba
has two stages in its life cycle, an active trophozoite
stage that exhibits vegetative growth and a dormant cyst
stage with minimal metabolic activity. It is a causative
agent of cutaneous lesions and sinus infections, vision-
threatening keratitis and a rare but fatal encephalitis,
known as granulomatous amoebic encephalitis [1-3].
The ability of Acanthamoeba to (i) produce serious
human infections associated with a rise in the number
of immunocompromised patients and contact lens wear-
ers, (ii) their potential role in ecosystems, (iii) ability to
act as a host/reservoir for microbial pathogens, and (iv)
model organism for motility studies has led to a signifi-
cant interest in this organism over the years (Figure 1).
Furthermore, Acanthamoeba may have veterinary signif-
icance as demonstrated by the presence of amoebae in
diseased or dead cows, dogs, pigs, rabbits, pigeons,
sheep, reptiles, fish, turkeys, keel-billed toucan,
Ramphastos sulfuratus, horses [4-6].
Discovery of Amoebae
Amoebae are among the earliest eukaryotes that have
been studied since the discovery of the early microscope,
e.g., Amoeba proteus, or closely related Chaos that is a
genus of giant amoebae, varying from 1-5 mm in length.
Based on rRNA sequences, it is estimated that amoebae
have diverged from the main line of eukaryotic descent,
sometimes between the divergence of yeast (~1.2 × 109
years ago) and the divergence of plants and animals (~1
× 109 years ago). Over the past several decades, these
organisms have gained increasing attention due to their
diverse roles in the ecosystem and in particular, their
role in causing serious and sometimes fatal human
infections (Figure 2).
• Entamoeba histolytica is a parasitic protist that was
discovered in 1873 from a patient suffering from
bloody dysentery [7,8] and named E. histolytica in
1903 [9,10]. This species was separated into one
pathogenic (E. histolytica) and another non-patho-
genic (E. dispar) [11], which also is capable of pro-
ducing experimental lesions [12] and questioned by
some authors if really it is unable to cause human
disease [13].
• Naegleria is a free-living amoebae that was first
discovered by Schardinger in 1899, who named it
“Amoeba gruberi“. In 1912, Alexeieff suggested its
genus name as Naegleria, and much later in the
1970, Carter identified Naegleria fowleri as the cau-
sative agent of fatal human infections involving the
central nervous system (CNS) [14].
• Sappinia diploidea is a free-living amoeba that was
isolated from the faeces of lizards and from the soil
in 1908-09, and then described as a causative agent
of granulomatous amoebic encephalitis in 2001 [15].
• Balamuthia mandrillaris was discovered in 1986,
from the brain of a baboon that died of meningoen-
cephalitis and was described as a new genus, i.e.,
Balamuthia [3,16]. So far, only one species has been
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identified, B. mandrillaris. The majority of isolates
have been isolated from necropsies while organic-
rich soil has been suggested as a potential source.
Like Acanthamoeba, it is known to produce infec-
tions of the central nervous system, lungs, sinuses
and skin. Worryingly, granulomatous encephalitis
due to B. mandrillaris has been reported in immu-
nocompetent individuals indicating its potential
threat to human and animal health.
• In 1930, Acanthamoeba was discovered as a con-
taminant of yeast culture, Cryptococcus pararoseus
and was later placed in the genus Acanthamoeba,
and then described as a causative agent of Acantha-
moeba granulomatous encephalitis (AGE) in the
1960s and of keratitis in 1970s [17].
Biology of Acanthamoeba
The term acanth (Greek “acanth” means “spikes”) was
added to “amoeba” to indicate the presence of spine-like
structures (now known as acanthopodia) on its surface.
It contains one or more prominent contractile vacuoles,
whose function is to expel water for osmotic regulation
[18]. Other types of vacuoles in the cytoplasm include
lysosomes, digestive vacuoles and a large number of gly-
cogen-containing vacuoles. The plasma membrane con-
sists of proteins (33%), phospholipids (25%), sterols
(13%), and lipophosphonoglycan (29%) [19,20]. The
major phospholipids in Acanthamoeba are phosphatidyl-
choline (45%), phosphatidylethanolamine (33%), phos-
phatidylserine (10%), phosphoinositide (6%), and
diphosphatidylglycerol (4%). The main fatty acids chains
in Acanthamoeba are oleic acids (40-50%), and longer
polyunsaturated fatty acids (20-30%) [21]. Acantha-
moeba contains low levels of glycolipids. Glucose
accounts for about 60% of the sugars of the glycolipids
of the whole cells and of the plasma membranes.
Among sterols, the non-saponifiable fraction of the total
lipids extracted from the trophozoites of pathogenic
Acanthamoeba possesses ergosterol and 7-dehydrostig-
masterol [20]. Acanthamoeba has been shown to pro-
duce prostaglandins [22].
Acanthamoeba trophozoite possesses large numbers of
mitochondria (Figure 3). The genome size of mitochon-
drial DNA from A. castellanii belonging to T4 genotype
is 41,591 bp [23]. Acanthamoeba normally possesses a
single nucleus that is approximately one sixth the size of
trophozoite (Figure 3), but multinucleate amoebae have
been observed. The genome size of A. castellanii Neff
strain, belonging to T4 genotype is approximately 45
Mb http://www.hgsc.bcm.tmc.edu/microbial-detail.xsp?
project_id=163. Based on the coding sequence (CDS fea-
tures, exon) analysis of 200 genes, it was calculated that
there are on average 3 exons per gene (for comparison,
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Figure 1 Increasing scientific interest in the field of free-living amoebae as determined by published articles over the last five
decades. A pubmed search using “Acanthamoeba“, “Balamuthia“, Naegleria“ or “Sappinia“ was carried out.
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E. histolytica possess 1.3 exons per gene, and Dictyoste-
lium discoideum possess 2.3 exons per gene) [24].
Acanthamoeba has long been studied as a model
eukaryotic cell with special emphasis on the actin cytos-
keleton-based motility [25]. Acanthamoeba moves rela-
tively fast compared to other cells, with a locomotory
rate of approximately 0.8 μm/second. The movement
involves the formation of a hyaline pseudopodium. The
manner of Acanthamoeba movement is similar both at
solid substrata and water-air interface. Adhesion forces
developed between Acanthamoeba and the water-air
interface are greater than gravity, and thus amoebae are
also transported passively without detachment from the
water surface [26]. Actin microfilaments are most con-
centrated just beneath the plasma membrane, and are
responsible for resisting tension and forming cytoplas-
mic protrusions.
Life cycle of Acanthamoeba
Acanthamoeba has two stages in its life cycle, a vegeta-
tive trophozoite stage with a diameter of 13-23 μm and
dormant cyst stage of 13-23 μm (Figure 4). During the
trophozoite stage (Greek “tropho” means “to nourish”),
Acanthamoeba feeds on organic particles as well as
other microbes and divides mitotically under optimal
conditions (food supply, neutral pH, ~30°C) and 50-
80mOsmol [27]. Exposure to harsh conditions result in
cellular differentiation into a double-walled cyst form
[28]. The outer walls consists of proteins and polysac-
charides, while the inner wall possesses cellulose
[29-31]. Both walls are normally separated by a space,
except at certain points where they form opercula in the
centre of ostioles (exit points for excysting trophozoite).
The cyst wall composition for A. castellanii belonging
to T4 genotype has been shown to contain 33% protein,
4 - 6% lipid, 35% carbohydrates (mostly cellulose), 8%
ash, and 20% unidentified materials [29-31]. Using gas
chromatography combined with mass spectrometry, the
carbohydrate composition of cyst walls revealed a high
percentage of galactose and glucose and small amounts
of mannose and xylose [32]. Linkage analysis revealed
several types of glycosidic linkages including the 1,4-
linked glucosyl conformation indicative of cellulose
(Table 1).
Kingdom of 
organisms
Prokaryotes
Fungi
Protists
Animals
Plants
Parabasala, e.g., Trichomonas, Dientamoeba
Radiolaria
Ciliates, e.g., Balantidium  
Apicomplexans, e.g., Plasmodium, Cryptosporidium, 
Toxoplasma, Babesia, Isospora    
Alveolata
Cercozoa
Amoebozoa
Diplomonadida, e.g., Giardia 
Euglenozoa
Stramenopila, e.g., Blastocystis 
Rhodophyta
Free-living & parasitic forms, e.g., Acanthamoeba, 
Balamuthia, Entamoeba  
Kinetoplastids, e.g., Trypanosoma, Leishmania, Naegleria 
Figure 2 The classification of protists, based on ribosomal rRNA sequences (modified from Khan NA Acanthamoeba: Biology and
Pathogenesis, Caister Academic Press, 2009, ISBN: 978-1-904455-43-1).
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Figure 3 The transmission electron micrograph of Acanthamoeba trophozoite. M is mitochondria; N is nucleus; V is vacuole and arrow
indicates plasma membrane.
Figure 4 The life cycle of Acanthamoeba spp. Under favourable conditions, Acanthamoeba remains in the trophozoite form and
divides mitotically (A) and produces infection, while under harsh conditions amoeba transforms into a dormant cyst form (B) that is
highly resistant to harsh conditions.
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Distribution in the environment and clinical settings
Acanthamoeba has been isolated from diverse natural
environments including sea water, ocean sediments, bea-
ches, pond water, soil, fresh water lakes, hot spring
resorts, salt water lakes, Antarctica, water-air interface,
and even from the air. They have been isolated from
bottled mineral water, distilled water bottles, thermally-
polluted factory discharges, cooling towers of the elec-
tric and nuclear power plants, Jacuzzi tubs, ventilation
ducts, humidifiers, air-conditioning units, shower heads,
kitchen sprayers, sewage, compost, vegetables, surgical
instruments, contact lenses and their cases, pigeon drop-
pings, fresh water fish, as well as other healthy, diseased,
and dead animals. They have been recovered from hos-
pitals, physiotherapeutical swimming pools, dialysis
units, portable and stationary eye wash stations, human
nasal cavities, throat, pharyngeal swabs, lung tissues,
skin lesions, human faeces, corneal biopsies, maxillary
sinus, mandibular autografts, stool samples, urine of cri-
tically ill patients, cerebrospinal fluids and the brain
necropsies. Based on the above, it is accepted that
Acanthamoeba is ubiquitously present in the environ-
ment and that we commonly encounter this organism in
our routine lives as evidenced by the presence of anti-
Acanthamoeba antibodies in up to 100% healthy popula-
tions in New Zealand and more than 85% in individuals
of London that came from different countries [33,34].
Role in the Ecosystem
In soil, protists such as amoebae, flagellates and ciliates
have two major ecological roles: (i) influencing the
structure of the microbial community, and (ii) enhan-
cing nutrient recycling. Both of these activities are asso-
ciated with soil protists feeding on bacteria thus
regulating bacterial populations in the soil. Among
protists, free-living amoebae are the dominant bacterial
consumers and are responsible for up to 60% of the
total reduction in bacterial population [35]. The primary
decomposers (bacteria) directly decompose organic
materials but are inefficient in releasing minerals from
their own mass. The secondary decomposers, such as
free-living amoebae, consume the primary decomposers
and release mineral nutrients as waste products that are
tied up in the primary decomposer’s biomass. In this
way, protists such as Acanthamoeba (as well as other
grazers) make nutrients available that would otherwise
remain inaccessible for much longer. The soil containing
Acanthamoeba and bacteria showed significantly greater
mineralization of carbon, nitrogen, and phosphorous
compared with the soil containing bacteria but without
Acanthamoeba [36,37]. As well as bacterial consump-
tion, amoebae promote bacterial populations in the soil.
The mineral regeneration by the secondary decomposers
(protists such as amoebae), relieved nutrient limitation
for the primary decomposers. This was demonstrated
with the findings that when nitrogen was limiting (but
carbon present), nitrogen mineralization by Acantha-
moeba permitted continued growth of bacteria (Pseudo-
monas paucimobilis) resulting in a greater bacterial
biomass [36,37]. And when carbon was limiting,
Acanthamoeba was almost entirely responsible for nitro-
gen mineralization, with bacteria (Pseudomonas pauci-
mobilis) contributing little. Using an experimental
model system, the effects of grazing by Acanthamoeba
on the composition of bacterial communities in the rhi-
zosphere of Arabidopsis thaliana demonstrated reduc-
tion in bacterial populations leading to positive effect on
plant growth [35-37]. Overall, Acanthamoeba appears to
play an important role in the regulation of bacterial
populations in the environment and the nutrient cycling,
thus contributing to the functioning of the ecosystems.
Genotyping
Based on rRNA gene sequences, the genus Acanthamoeba
is divided into 17 different genotypes to date (T1 - T17)
(Table 2) [38-41]. Each genotype exhibits 5% or more
sequence divergence between different genotypes. The
majority of human infections due to Acanthamoeba have
been associated with the isolates of the T4 genotype. For
example, more than 90% of Acanthamoeba keratitis (AK)
cases have been linked with this genotype. Similarly, T4
has been the major genotype associated with the non-ker-
atitis infections such as AGE and cutaneous infections. At
present, it is unclear why T4 isolates are most abundant in
human infections but it is likely due to their greater viru-
lence and properties that enhance their transmissibility as
well as their reduced susceptibility to chemotherapeutic
agents. Future studies will identify virulence traits and
genetic markers limited only to certain genotypes, which
Table 1 Glycosyl linkage analysis of Acanthamoeba
castellanii cyst wall saccharides (reproduced with
permission from Dudley et al., 2009).
Glycosyl Residue1 Area2 Percentage Present
Terminal Mannopyranose 563313 3.2
5 linked Xylofuranose/4XylP 1236950 7.0
3 linked Galactopyranose 5038076 28.6
4 linked Glucopyranose 3908275 22.2
3,4 linked Galactopyranose 2392068 13.6
3,4 linked Glucopyranose 1063116 6.0
2,4 linked Gluco or Galactopyranose 783793 4.4
4,6 linked Mannopyranose 1368136 7.8
3,6 Linked Galactopyranose 1273911 7.2
1Note that 5 linked xylofuranose and 4-linked xylopyranose are not
distinguished in this assay as they have the same derivative. 2Area
percentages are not corrected for response factor and thus may not be
representative of molar ratios.
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may help clarify these issues. A current list of genotypes
and their association with the human infections is pre-
sented in Table 2.
Acanthamoeba keratitis
Although it can occur in non-contact lens wearers, it is
mostly associated with the use of contact lenses. Overall
this is a multifactorial process involving (i) contact lens
wear for extended periods of time, (ii) lack of personal
hygiene, (iii) inappropriate cleaning of contact lenses,
(iv) biofilm formation on contact lenses, and (v) expo-
sure to contaminated water [3]. The sequence of events
in AK involves breakdown of the epithelial barrier, stro-
mal invasion by amoebae, keratocyte depletion, induc-
tion of an intense inflammatory response, photophobia
and finally stromal necrosis with blinding consequences
(Figure 5) [42,43]. Recent studies have reported a signifi-
cant increase in the number of AK patients in the USA,
Australia, Italy, New Zealand, and Brazil [44-48]. This is
further supported with 2 recent outbreaks of AK where
a dramatic rise was seen in tertiary care centers in Sin-
gapore and the United States [49]. At present there are
more than 120 million people wearing contact lenses,
throughout the world, thus there is a growing need to
be aware of the associated risks. This is particularly
important in view of the ineffectiveness of cleaning solu-
tions of some contact lens products. For example in
2006, Bausch & Lomb (USA) voluntarily withdrew their
contact lens solution “ReNu with MoistureLoc contact
lens solution” from the market. This was a result of an
outbreak of eye infection in the contact lens wearers
http://www.drugattorneys.com/fda-reports/fusariumkera-
titis-051906.cfm resulting in hundreds of lawsuits being
brought against Bausch & Lomb. The company recog-
nized the problem and removed all ReNu with Moisture-
Loc products worldwide. This is not a one-off. Since the
discovery of the first corneal lenses in 1949, there have
been several outbreaks of contact lens-associated infec-
tions throughout the world with microbial ones being the
most serious ones. Time and time again, the negligence
of many manufacturers has been highlighted. For exam-
ple in 2005, Dr. Epstein alerted Bausch & Lomb of the
Table 2 Known Acanthamoeba genotypes and their
associations with human diseases, i.e., keratitis and
granulomatous encephalitis.
Acanthamoeba genotypes Human disease association
T1 Encephalitis
^T2a Keratitis, Encephalitis
^T2b - ccap1501/3c-alike sequences NA
T3 Keratitis
T4* Keratitis, Encephalitis
T5 Keratitis, Encephalitis
T6 Keratitis
T7 NA
T8 NA
T9 NA
T10 Keratitis, Encephalitis
T11 Keratitis
T12 Encephalitis
T13 NA
T14 NA
T15 Keratitis
T16 NA
T17 NA
*this genotype has been most associated with both diseases
^basis of T2 division into T2a and T2b has been proposed by Maghsood
et al., (2005)
NA - no disease association has been found yet
Figure 5 (A) Normal eye and (B) Infected eye exhibiting recurrent Acanthamoeba infection following corneal transplant with severe
corneal damage and loss of vision.
Siddiqui and Khan Parasites & Vectors 2012, 5:6
http://www.parasitesandvectors.com/content/5/1/6
Page 6 of 13
ineffectiveness of their ReNu with MoistureLoc contact
lens solution to kill Fusarium, a claim that was rejected
by the manufacturer. Again, in 2007, the Centers for Dis-
ease Control and Prevention (CDC) issued a public
health alert about an increased AK risk. This outbreak
was linked primarily to Complete Moisture Plus No-Rub
contact lens solution. The manufacturer, Advanced Med-
ical Optics (AMO), had voluntarily recalled the solution
and was encouraging consumers not to use it until
further information was available. Overall, there is a clear
need to be aware of the associated risks of the contact
lens use, particularly in developing countries, where
health surveillance may not be appropriate.
Diagnosis
The diagnosis of AK is problematic and it is often mis-
diagnosed as bacterial, viral or fungal keratitis. The use
of contact lenses by the patient together with excruciat-
ing pain is strongly indicative of this infection. The use
of in vivo confocal microscopy has emerged as a valu-
able non-invasive tool for the clinical diagnosis in severe
infectious keratitis with high sensitivity [50,51]. The
confirmatory evidence comes from demonstrating para-
sites using laboratory-based assays. The cultivation of
Acanthamoeba from the corneal biopsy or from contact
lenses/cases remains the most widely used assay. Immu-
nofluorescence assays and multiplex real-time PCR
methods [52] have also been developed. The multiplex
assay is of value for the simultaneous detection of
pathogenic free-living amoebae in the same sample. The
use of real-time fast-duplex TaqMan PCR for the simul-
taneous detection of 10 different genotypes of Acantha-
moeba can detect 0.1 cyst/μl [53]. In addition, matrix-
assisted laser desorption-ionization time-of-flight mass
spectrometry and 1H NMR spectroscopy has been
shown to be of potential value in the rapid identification
of Acanthamoeba in the clinical specimens.
Treatment
Early diagnosis followed by aggressive treatment is
essential for the successful prognosis. No single agent is
shown to be uniformly effective against all isolates/geno-
types of Acanthamoeba. Multiple factors including var-
ied clinical presentation and virulence of Acanthamoeba
account for a lack of correlation between in vitro activity
and in vivo efficacy. The treatment regimen includes
polyhexamethylene biguanide or chlorhexidine digluco-
nate together with propamidine isethionate or hexami-
dine, is effective. If bacteria are also associated with the
infection, addition of antibiotics, i.e., neomycin or chlor-
amphenicol is recommended [54].
Acanthamoeba granulomatous encephalitis
AGE is a rare infection but it almost always proves fatal.
It is of major concern in view of increasing numbers of
immunocompromised patients who are susceptible
hosts, individuals undergoing immunosuppressive ther-
apy and excessive use of steroids. Individuals with lym-
phoproliferative or hematologic disorders, diabetes
mellitus, pneumonitis, renal failure, liver cirrhosis or
other hepatic diseases, gamma-globulinaemia or patients
undergoing organ/tissue transplantation with immuno-
suppressive therapy, steroids and excessive antibiotics
are at risk [55,56]. The gross pathology of the autopsied
brains show severe edema and haemorrhagic necrosis.
The microscopic findings of the post-mortem necropsies
reveal amoebae cysts, predominantly in the perivascular
spaces in the parenchyma indicating involvement of the
cerebral capillaries as the sites of amoebae entry into
the CNS. It is widely accepted that the route of entry
for Acanthamoeba include the respiratory tract leading
to amoebae invasion of the alveolar blood vessels, fol-
lowed by the haematogenous spread. Acanthamoeba
entry into the CNS most likely occurs through the
blood-brain barrier [55,56]. As AGE is a secondary
infection, it is difficult to determine its true burden on
human health. The approximate rate of AGE-associated
deaths has been suggested as 1.57 deaths per 10,000
HIV/AIDS deaths [3].
Diagnosis
The symptoms of AGE are similar to other CNS infec-
tions including virus, bacteria and fungi. The neurologi-
cal manifestations of AGE may vary and include
headache, fever, behavioral changes, hemiparesis,
lethargy, stiff neck, agitation, aphasia, ataxia, vomiting,
nausea, cranial nerve palsies, increased intracranial pres-
sure, seizures, and coma [55,56]. The magnetic reso-
nance imaging or computerized tomography of the
brain shows ring-enhancing lesions exhibiting a single
or multiple space-occupying mass in the cerebral cortex
but severely immunocompromised patients may not
exhibit such lesions. The CSF findings shows pleocytosis
with lymphocytic predominance, increased protein con-
centrations, decreased glucose concentrations and mini-
mal cloudiness [2], however the CSF may be devoid of
cells in HIV-positive patients. High levels of Acantha-
moeba-specific antibodies in patient’s serum is indicative
of AGE infection. The antibody levels in normal popula-
tions may be in the range of 1:20 to 1:60 [33,57] but
patients with severely impaired immune system may not
develop a high titre. The confirmatory evidence comes
from demonstration of amoebae in the infected tissues.
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Treatment
There is no recommended treatment and the majority of
cases are diagnosed at the post-mortem stage. A lack of
available antiamoebic compounds together with selectiv-
ity of the blood-brain barrier has led to more than 90%
mortality rate. Few successful cases involved the use of
ketoconazole, fluconazole, sulfadiazine, pentamidine
isethionate, amphotericin B, azithromycin, itraconazole,
or rifampicin [1,58,59] but overall the prognosis remains
poor.
Pathogenesis
Parasite adhesion to the host cell is a primary step and
is mediated by a 130 kDa mannose-binding protein
(MBP) expressed on the surface of Acanthamoeba [60].
Acanthamoeba mbp consists of 6 exons and 5 introns
that spans 3.6 kbp. The 2.5 kbp cDNA codes for an 833
amino acids precursor protein with a signal sequence
(residues 1-21aa), an N-terminal extracellular domain
(residues 22-733aa) with five N- and three O-glycosyla-
tion sites, a transmembrane domain (residues 734-
755aa), and a C-terminal intracellular domain (residues
756-833aa). Other adhesins include a laminin-binding
protein with a predicted molecular mass of a 28.2 kDa,
a 55 kDa laminin-binding protein and a > 207 kDa
adhesin [61,62]. The initial binding leads to secondary
events such as phagocytosis and toxin production result-
ing in the host cell death in a phosphotidylinositol 3-
kinasedependent (PI3K) manner [63]. The downstream
effectors of PI3K involves activation of proapoptotic
molecules, Bak and Bax, loss of mitochondrial mem-
brane potential and release of cytochrome c as well as
caspase activation, all well-known mediators of the
apoptosis [64-66]. Among host cell receptors, Toll-like
receptor 4 (TLR4) showed involvement in Acantha-
moeba recognition and exerting an effect through adap-
tor protein, Myeloid differentiation primary response 88
that led to the activation of transcription factors, nuclear
factor-kappa B signalling through extracellular signal-
regulated kinases (ERKs) inducing the secretion of cyto-
kines including interleukin-8, tumor necrosis factor-
alpha and interferon-beta in human corneal cells [67].
Using human brain microvascular endothelial cells
(HBMEC), which constitute the blood-brain barrier, it is
shown that Acanthamoeba abolished the HBMEC trans-
endothelial electrical resistance by degrading occludin
and zonula occludens-1 tight junction proteins in a Rho
kinase-dependent manner leading to increased perme-
ability [68].
Other factors that may contribute to Acanthamoeba
pathogenesis include ecto-ATPases of approximate
molecular weights of 62, 100, 218, 272, > 300 kDa [66]
and these are involved in caspase-3 activation (Figure 6)
[69]. The neuraminidase activities of Acanthamoeba
could be relevant in the colonization of the parasite, and
also important in producing damage of the sialic acid-
rich corneal epithelium and in the alterations of glycoli-
pids associated with meningoencephalitis. Interestingly,
the neuraminidases of Trypanosoma cruzi and Acantha-
moeba are immunologically related as demonstrated by
antibodies against neuraminidase of Trypanosoma cruzi,
which reacted with Acanthamoeba [70]. Two superoxide
dismutases have been identified in Acanthamoeba: an
iron superoxide dismutase (~50 kDa) and a copper-zinc
superoxide dismutase (~38 kDa). The superoxide dismu-
tase catalyzes the dismutation of the superoxide into
oxygen and hydrogen peroxide and play a role in antiox-
idant defence. These enzymes may provide additional
targets for chemotherapy and immuno-diagnosis of
Acanthamoeba infections. Acanthamoeba has been
shown to display plasminogen activator activity by cata-
lyzing the cleavage of host plasminogen to form plas-
min, which can activate host matrix metalloproteinases
leading to degradation of the basement membranes.
Of contact-independent factors, Acanthamoeba pos-
sess hydrolytic enzymes including elastases [71], phos-
pholipases [72], glycosidases and a variety of serine,
cysteine and metalloproteases (Figure 6) [2,3,42,43].
However, their precise mechanisms of action at the
molecular-level are only beginning to emerge. That
some of the above proteases are secreted only by the
clinical isolates may indicate their role as potent viru-
lence factors and/or diagnostic targets. Future studies in
the role of proteases as vaccine targets, search for novel
inhibitors by screening of chemical libraries, or rational
development of drugs based on structural studies will
enhance our ability to target this pathogen. Overall, the
mechanism by which Acanthamoeba breaches biological
barriers is complex and is likely to involve both parasite
(adhesins, proteases, phospholipases) as well as host
determinants [interleukin-beta, interleukin-alpha, tumor
necrosis factor- alpha, interferon-gamma, host cell apop-
tosis]. In addition to aforementioned potential virulence
factors, the ability of Acanthamoeba to survive harsh
environmental conditions and its resistance to che-
motherapeutic drugs by differentiating into cysts contri-
butes to its pathogenicity.
Immune response to Acanthamoeba infections
The recurrence of AK infections is common, suggesting
that the corneal infection alone does not induce protec-
tive immunity against the parasite antigens. Experimen-
tal animals immunized orally with Acanthamoeba
antigens mixed with the cholera toxin showed signifi-
cantly lower infection rates compared with the control
groups (21.4% versus 72.6% respectively) and protection
was associated with higher levels of parasite-specific
sIgA. More specifically, oral immunization using
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recombinant MBP improved AK and protection was
associated with the presence of elevated levels of anti-
MBP sIgA in tears of the immunized animals [73]. Simi-
larly, oral immunization with a serine protease (~133
kDa) reduced the severity of the corneal infection by
modulating MMP-2 and MMP-3 expression [74]. Over-
all, it is suggested that AK patients show decreased
overall levels of sIgA as well as specific anti-Acantha-
moeba sIgA, however the role of sIgA was questioned in
a recent study in which neither normal tears nor AK
tears had any protective effects on Acanthamoeba-
mediated corneal epithelial cell cytotoxicity. Tear fac-
tors, in addition to sIgA such as lysozyme, lactoferrin,
beta-lysins, prostoglandins, and other compounds with
antimicrobial and immunological properties were also
shown to have no significant effects on Acanthamoeba-
mediated binding to and cytotoxicity of human corneal
epithelial cells [75]. Tears also contain complement that
is composed of serum-borne molecules in a cascade-like
manner. Acanthamoeba directly activates the comple-
ment system via the alternative pathway, however patho-
genic amoebae are resistant to complement-mediated
lysis due to expression of complement regulatory pro-
teins including decay accelerating factor [76]. The pre-
sence of macrophages in corneas exposed to the
parasite-laden contact lenses prevented the development
of full-blown AK in vivo by inducing an inflammatory
response, in particular secretion of macrophage inflam-
matory protein-2 [77].
For AGE, immunization with Acanthamoeba antigens
using intranasal, intraperitoneal, intravenous or oral
routes of administration had a protective effect validat-
ing that AGE is limited to individuals with a weakened
immune response. The complement pathway and
Phenotypic switching
Morphology
Ubiquity Osmotolerance
Indirect virulence Physiological tolerance Temp tolerance  
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Figure 6 Acanthamoeba pathogenesis involves contact-dependent and -independent factors together with indirect virulence features
(taken from Khan NA Acanthamoeba: Biology and Pathogenesis, Caister Academic Press, 2009, ISBN: 978-1-904455-43-1).
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antibodies in the presence of phagocytes show potent
lytic activity against Acanthamoeba in a contact-depen-
dent manner. These interactions also stimulate secretion
of pro-inflammatory cytokines including interleukin-1-
beta, interleukin-6 and tumor necrosis factor-alpha
[76-79]. Other studies in mice have shown significant
increased natural killer cell activities in Acanthamoeba-
infected animals suggesting that natural killer cells may
also play a role in the protective immunity [80]. Overall,
a debilitated immune status of the host is a pre-requisite
in AGE but the underlying mechanisms together with
the role of the host ethnic origin (i.e., genetic predispo-
sition) remain incompletely understood. Pathogenic
Acanthamoeba are shown to degrade chemokines and
cytokines, antibodies, complement pathway, and macro-
phages [76,81,82].
Future prospects for treatment
A murine monoclonal anti-idiotypic antibody and a syn-
thetic killer mimotope (mimics a yeast killer toxin)
showed broad spectrum anti-amoebic activities suggest-
ing their potential use in the prevention and therapy of
Acanthamoeba infections [83]. The Fab fragment of a
monoclonal antibody specifically reactive to A. castella-
nii cell surface was covalently linked to the A chain of
diphtheria toxin [84]. This immunotoxin inhibited cell
division completely, suggesting that specific antibodies
coupled with cytotoxic agents could be a useful method
in the development of therapeutic interventions or pre-
ventative measures. To enhance the potency of available
drugs, propamidine isethionate combined with dimethyl-
sulfoxide proved to be highly effective suggesting that
use of a carrier for known anti-amoebic drugs may
increase their penetration into the cyst form of the
organism, which is normally refractory to drug treat-
ment. To this end, the use of liposomes has been shown
to improve the potency of pentamidine isethionate in
vitro [85]. Similarly, the use of chitosan microspheres
improved in vitro anti-amoebic activity of rokitamycin.
Such methods will be useful in transporting the drug for
either ocular application to treat AK or nasal adminis-
tration as an alternative route for the administration of
the drug to the brain in AGE therapy. Small interfering
RNAs (siRNAs) against the catalytic domains of extra-
cellular serine proteases and glycogen phosphorylase
showed promise in the rational development of thera-
peutic interventions [86]. Photodynamic chemotherapy
by linking amoeba-specific antibodies with photosensiti-
zers such as phthalocyanine or Hypocrellins B may be
advantageous over conventional methods due to its loca-
lized use, in particular for eye infections. In addition, the
programmed cell death in protists has emerged as a fas-
cinating field of parasite biology and could serve as a
basis of novel anti-Acanthamoebic drugs [87-89].
Acanthamoeba: Trojan Horse of the Microbial World
The majority of Acanthamoeba isolates harbor endo-
symbionts which may include viruses, yeast, protists and
bacteria, some of which are potential human pathogens.
The exact nature of symbiosis and the benefit they
represent for the amoeba host are unknown. It is sug-
gested that such interactions may help transmit micro-
bial endosymbionts to the susceptible hosts and/or
endosymbionts may contribute to the pathogenicity of
Acanthamoeba [3,90]. Future studies in the identifica-
tion of virulence factors of the endosymbiont and of the
host, and their precise role in disease will clarify these
issues.
Acanthamoeba is known to host the largest known
virus, Mimivirus, initially mistaken for a parasitic bacter-
ium with a particle size of 400 nm and genome size of
1.2 million bp [91]. Among 911 protein coding genes,
10% exhibit similarity to proteins of known functions
blurring the established boundaries between viruses and
Archea/Bacteria, a finding that may have huge implica-
tions in our understanding of the evolutionary processes
[3,91].
Acanthamoeba is shown to harbour a variety of
viruses including coxsackieviruses, adenoviruses, polio-
virus, echovirus, enterovirus, or vesicular stomatitis
virus, and yeast, Cryptococcus neoformans, Blastomyces
dermatitidis, Sporothrix schenckii, Histoplasma capsula-
tum, Streptomyces californicus and Exophiala dermatiti-
dis, and protists including Cryptosporidium and
Toxoplasma gondii [3,91].
Among bacterial pathogens, Acanthamoeba are shown
to host/reservoir for Aeromonas spp., Bacillus cereus,
Bartonella spp., Burkholderia spp., Burkholderia picket-
tii, Campylobacter jejuni, Candidatus Odyssella thessalo-
nicensis, Chlamydophila pneumoniae, Coxiella burnetii,
Cytophaga spp., Escherichia coli O157, neuropathogenic
Escherichia coli K1, Flavobacterium spp., Francisella
tularensis, Helicobacter pylori, Legionella pneumophila,
Listeria monocytogenes, Staphylococcus aureus, Methicil-
lin-resistant Staphylococcus aureus, Mycobacteria tuber-
culosis, M. avium, M. leprae, Parachlamydia
Acanthamoebae, Pasteurella multocida, Prevotella inter-
media, Porphyromonas gingivalis, Pseudomonas aerugi-
nosa, Rickettsia, Salmonella typhimurium, Shigella
dysenteriae, S. sonnei, Simkania negevensis, Vibrio cho-
lerae, V. parahaemolyticus, Waddlia chondrophila as
well as novel bacterial endosymbionts that are related to
Caedibacter caryophilus, Holospora elegans and Holos-
pora obtuse, which were proposed as ‘Candidatus Cae-
dibacter Acanthamoebae’, ‘Candidatus Paracaedibacter
Acanthamoebae’ and ‘Candidatus Paracaedibacter sym-
biosus’ suggesting the usefulness of amoeba co-culture
to recover novel chlamydial strains [3,91]. With the
remarkable implications of parasite-parasite interactions,
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which may contribute to the evolution of one (either
bacteria or Acanthamoeba) or both parasites to become
successful human and animal pathogens and transmis-
sion of microbial pathogens in the environment, this
area of research is of particular significance.
Conclusions
Acanthamoeba has gained increasing attention from the
scientific community studying cellular microbiology,
environmental biology, physiology, cellular interactions,
molecular biology, biochemistry and the evolutionary
studies. This is due to their versatile roles in the ecosys-
tem and their ability to capture prey by phagocytosis
(similar to macrophages), act as vectors, reservoirs and
as a Trojan horse for microbial pathogens, and to pro-
duce serious human infections including a blinding ker-
atitis and fatal encephalitis. This unicellular organism has
been used extensively to understand the molecular biol-
ogy of cell motility. Being a eukaryote, Acanthamoeba
presents an excellent model for cell differentiation stu-
dies. The recent availability of the Acanthamoeba gen-
ome, together with the development of transfection
assays and the RNA interference methods [86] will
undoubtedly increase the pace of our understanding of
this complex but fascinating organism.
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